Abstract:Rationale: Noxious stimuli are often perceived as itchy in patients with chronic dermatitis (CD); however, itch and pain mechanisms of CD are not known. Methods: TRPV1 involvement in CD was analyzed using a SADBE induced CD-like mouse model, and several loss- and gain-of-function mouse models. Trigeminal TRPV1 channel and MrgprA3+ neuron functions were analyzed by calcium imaging and whole-cell patch-clamp recordings. Lesional CD-like skin from mice were analyzed by unbiased metabolomic analysis. 20-HETE availability in human and mouse skin were determined by LC/MS and ELISA. And finally, HET0016, a selective 20-HETE synthase inhibitor, was used to evaluate if blocking skin TRPV1 activation alleviates CD-associated chronic itch or pain. Results: While normally a pain inducing chemical, capsaicin induced both itch and pain in mice with CD condition. DREADD silencing of MrgprA3+ primary sensory neurons in these mice selectively decreased capsaicin induced scratching, but not pain-related wiping behavior. In the mice with CD condition, MrgprA3+ neurons showed elevated ERK phosphorylation. Further experiments showed that MrgprA3+ neurons from MrgprA3;Braf mice, which have constitutively active BRAF in MrgprA3+ neurons, were significantly more excitable and responded more strongly to capsaicin. Importantly, capsaicin induced both itch and pain in MrgprA3;Braf mice in an MrgprA3+ neuron dependent manner. Finally, the arachidonic acid metabolite 20-HETE, which can activate TRPV1, was significantly elevated in the lesional skin of mice and patients with CD. Treatment with the selective 20-HETE synthase inhibitor HET0016 alleviated itch in mice with CD condition. Conclusion: Our results demonstrate that 20-HETE activates TRPV1 channels on sensitized MrgprA3+ neurons, and induces allokinesis in lesional CD skin. Blockade of 20-HETE synthesis or silencing of TRPV1-MrgprA3+ neuron signaling offers promising therapeutic strategies for alleviating CD-associated chronic itch.

Sensory TRP channels contribute differentially to skin inflammation and persistent itch

TRPA1 controls inflammation and pruritogen responses in allergic contact dermatitis

TRPV1 SUMOylation suppresses itch by inhibiting TRPV1 interaction with H1 receptors

Transient receptor potential vanilloid 4-expressing macrophages and keratinocytes contribute differentially to allergic and nonallergic chronic itch.

Toll-Like Receptor 4 Contributes to Chronic Itch, Alloknesis, and Spinal Astrocyte Activation in Male Mice

TLR3 Deficiency Impairs Spinal Cord Synaptic Transmission, Central Sensitization, and Pruritus in Mice.

Sensory neuron–expressed TRPC3 mediates acute and chronic itch

S1P/S1PRs-TRPV4 Axis is a Novel Therapeutic Target for Persistent Pain and Itch in Chronic Dermatitis

20-HETE mediated TRPV1 activation drives allokinesis via MrgprA3 + neurons in chronic dermatitis

A pivotal role for the activation of TRPV3 channel in itch sensations induced by the natural skin sensitizer carvacrol

TRPV1 Mediates Itch‐associated Scratching and Skin Barrier Dysfunction in DNFB‐induced Atopic Dermatitis Mice

Vascular Endothelial Growth Factor a Promotes Chronic Itch via VEGFA-VEGFR2-PI3K-TRPV1 Axis in Allergic Contact Dermatitis

TRPV4-β-catenin axis is a novel therapeutic target for dry skin-induced chronic itch

Facilitation of TRPV4 by TRPV1 is required for itch transmission in some sensory neuron populations.

TNF-α/TNFR1 Signaling is Required for the Full Expression of Acute and Chronic Itch in Mice Via Peripheral and Central Mechanisms.

Activation of Different Heterodimers of TLR2 Distinctly Mediates Pain and Itch.

Chemokine Receptor CXCR3 in the Spinal Cord Contributes to Chronic Itch in Mice

CXCR3 chemokine receptor signaling mediates itch in experimental allergic contact dermatitis

Inflammatory mediators causing cutaneous chronic itch in some diseases via transient receptor potential channel subfamily V member 1 and subfamily A member 1

LPS exacerbates TRPV4-mediated itch through the intracellular TLR4-PI3K signalling

Upregulation of DRG protein TMEM100 facilitates dry-skin-induced pruritus by enhancing TRPA1 channel function